<scp>YRDC</scp> is a Prognostic‐Related Biomarker Correlated With Immune Infiltration and Drug Sensitivity in Pan‐Cancer
Our study identifies YRDC as a novel therapeutic target and a promising biomarker for cancer progression, immunotherapy response, and targeted drug sensitivity across pan-cancers. These findings provide evidence for further research into YRDC's role in cancer biology and future clinical exercises.
Authors
- Yuetong Zhang (ORCID: https://orcid.org/0009-0003-6302-777X)
- Qiao Li (ORCID: https://orcid.org/0000-0002-4547-1266)
- Pin Huang (ORCID: https://orcid.org/0000-0002-3683-9479)
Institutions
- Sun Yat-sen University (CN)
- Nanfang Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cnr2.70325
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04